KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma.
Nadal E, Chen G, Prensner JR, Shiratsuchi H, Sam C, Zhao L, Kalemkerian GP, Brenner D, Lin J, Reddy RM, Chang AC, Capellà G, Cardenal F, Beer DG, Ramnath N.
Nadal E, et al. Among authors: cardenal f.
J Thorac Oncol. 2014 Oct;9(10):1513-22. doi: 10.1097/JTO.0000000000000305.
J Thorac Oncol. 2014.
PMID: 25170638
Free article.